Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic SteatohepatitisJianhui Zhu, David M. Lubman, Junfeng Huang et al.|Journal of Proteome Research|2020Cited by 53
A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM EvaluationYu Lin, David M. Lubman, Jocelyn Olivares et al.|Journal of Proteome Research|2021Cited by 34
Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry MethodYu Lin, David M. Lubman, Jianhui Zhu et al.|ACS Omega|2022Cited by 17
A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM EvaluationYu Lin, David M. Lubman, Jie Zhang et al.|Frontiers in Oncology|2022Cited by 15
Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MSYifei Tan, David M. Lubman, Jianhui Zhu et al.|ACS Omega|2023Cited by 12